Signed An Agreement With Lifesci Venture Partners To Collaborate On Open Innovation Through A Fund
Nov 2 (Reuters) - SK Biopharmaceuticals Co Ltd 326030.KS :
* SK BIOPHARMACEUTICALS CO - SIGNED AN AGREEMENT WITH
LIFESCI
VENTURE PARTNERS TO COLLABORATE ON OPEN INNOVATION THROUGH A
FUND
Source text for Eikon: ID:nPn2cgCNqa
Further company coverage: 326030.KS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SK Biopharmaceuticals Co
See all newsInsilico Medicine hits 3-week high on SK Biopharmaceuticals tie-up
Signs Joint Rd Partnership Agreement With Insilico Medicine
Brief: Insilico Medicine Cayman TopCo Says Co & SK Biopharmaceuticals Enter AI-Powered RD Collab Worth Up To $2.5 Bln
Brief: SK Life Science Announces FDA Acceptance For Review Of New Drug Application For Cenobamate Oral Suspension
Announces Pharmaceutical Supply Contract